A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients.

ABSTRACT:

Background

Patients with prostate cancer (PC) may be ready to make trade-offs between their quantity and their quality of life. For instance, elderly patients may prefer the absence of treatment if it is associated with a low-risk of disease progression, compared to treatments aiming at preventing disease progression but with a substantial deterioration of their Health-Related Quality of Life (HRQoL). Therefore, it seems relevant to compare the treatments by considering both survival and HRQoL. In this mini-review, the aim was to question whether the potential trade-offs between survival and HRQoL are considered in high impact factor journals.

Methods

The study was conducted from the PubMed database for recent papers published between May 01, 2013, and May 01, 2015. We also

SUBMITTER: Foucher Y 

PROVIDER: S-EPMC5836440 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature